Currently, BCPC's 12-month EPS stands at $4.6, according to the most recent financial reports. During 2024, BCPC reported a per-share earnings of $3.97, which shows a rise compared to the EPS of $3.38 recorded in 2023. BCPC recorded an EPS of $1.25 for the quarterly period ending on Sep 30, 2025.
In 2024, Balchem's earnings per share was $3.97, a rise of 17.5% from $3.38 in 2023. Over the quarter ending Sep 30, 2025, the earnings per share came in at $1.25, reflecting a 19% increase compared to the same quarter a year earlier. As of September 2025, the TTM EPS is $4.6. During 2023, the annual earnings per share was $3.38, representing an increase of 2.7% compared to 2022.
Balchem has recorded a growth in earnings per share of 19% in the past 12 months (YoY, quarterly). During the past three years, BCPC registered an average yearly EPS growth of 10%. Balchem had an average annual EPS growth of 9.9% in the last five years. Over the last decade, BCPC had an average annual earnings per share growth of 8.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EMN Eastman Chemical Co | 10.1 | 2.8% | 6.9% | 7% |
| MMM 3M Co | 26.04 | 160% | -9.5% | -0.6% |
| BCPC Balchem Corp | 33.2 | 17.5% | 10% | 9.9% |
| STE STERIS plc | 37.01 | 62.9% | 35.6% | 5.3% |
| IFF International Flavors & Fragrances Inc | N/A | 109.5% | -5.1% | -25.2% |
| CDXS Codexis Inc | N/A | 20.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.